Biotech News 11 Jun 2025 Rapid Biomimetic Nanovaccine for Personalized Cancer Therapy A recent article in Nature Communications describes a nanovaccine platform designed to support the development of personalized cancer vaccines. This approach uses… Pantitra
Biotech News 06 Jun 2025 New mRNA vaccine is more effective and less costly to develop, study finds A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1,… Pantitra
Biotech News 04 Jun 2025 Machine Learning in Immunology: From Epitope Prediction to Smarter Vaccine Design Tracking how well vaccines work is more important than ever—especially with diseases like COVID-19 that keep evolving. But measuring vaccine… Pantitra
Biotech News 30 May 2025 B cell discovery could supercharge future vaccine development New research reveals how B cells balance mutation and clonal expansion to refine their antibodies. This discovery could lead to… Pantitra
Biotech News 25 Nov 2024 UVA Model Advances Rational Design of More Effective Maternal Vaccines for Newborns Newborns, with their developing immune systems, face high risks of infection in the critical early months of life. While maternal… Pantitra
Biotech News 10 Sep 2024 Scientists use AI to unlock protein structures of hundreds of viruses for the first time Scientists are pioneering the use of machine-learning artificial intelligence software to investigate viruses, revealing never-before-seen viral mechanisms which yield immediate… Pantitra
Biotech News 07 Sep 2024 Glasgow scientists use Google Deep Mind and Meta technology in bid to speed up vaccine development Virology researchers at Glasgow University say the breakthrough could help vaccine development. Photograph: University of Glasgow Glasgow scientists have turned… Pantitra
Biotech News 20 Mar 2024 New DNA Origami Platform, DoriVac, Opens New Path for Designer Cancer Vaccine Development The central ingredient of therapeutic cancer vaccines is antigens, which are preferentially produced or newly produced (neoantigens) by tumor cells… Pantitra
Biotech News 18 Jan 2024 Accelerating Recombinant Protein Vaccine Development WuXi Vaccines describes technologies that hasten the progress from vaccine discovery to commercialization Recombinant protein vaccines, which are obtained by… Pantitra
